A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. (Q54210822)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. |
scientific article |
Statements
A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. (English)
Bacteroides fragilis
1 reference
Ayers LW
Aldridge KE
Gelfand M
Reller LB
Pierson CL
Schoenknecht F
Tilton RC
Wilkins J
Henderberg A
Schiro DD
1 April 1994
18
4
235-241